Skip to main content
. 2019 Mar 12;93(4):953–964. doi: 10.1007/s00204-019-02417-6

Fig. 4.

Fig. 4

Screening results of the DTP Oncology Set IV measured against parental A431 and its OATP2B1-expressing derivative (A431-2B1). Compounds displaying at least a threefold difference in toxicity (dashed line) between the control and transporter-expressing cells were considered as putative substrates (SR > 3, see inset)